Varicose Vein Treatment Market: Competitive Landscape by Treatment Mode

According to the new market research report "Varicose Vein Treatment Market in North America and Europe by Treatment Mode (Endovenous Ablation, Sclerotherapy, Stripping), Products (Laser & RF Ablation, Venous Closure, Surgical) – Forecasts to 2021?, published by MarketsandMarkets™, The varicose vein treatment market in North America and Europe is expected to reach USD 289.7 Million by 2021 from USD 207.9 Million in 2016, at a CAGR of 6.9% between 2016 and 2021.

Get 10% Free Customization on this report @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=22524107

varicose-vein-treatment-market

The report provides a detailed overview of the major drivers, restraints, opportunities, and challenges impacting the varicose vein treatment market in North America and Europe along with the estimates and forecasts of the revenue and market share analysis.

This report broadly segments the varicose vein treatment market into mode of treatment and products. The varicose vein treatment market, by products is segmented into ablation devices, venous closure products, and surgical products. The ablation devices segment is further categorized into radiofrequency ablation devices and laser ablation devices. On the basis of mode of treatment, the varicose vein treatment market is segmented into endovenous ablation, injection sclerotherapy, and surgical ligation/stripping.

Browse and in-depth TOC on "Varicose Vein Treatment Market"

67 – Tables

19 – Figures

149 – Pages

Request Bundle Reports @ https://www.marketsandmarkets.com/RequestBundleReport.asp?id=22524107

Objectives of the study are:

• To define, describe, and forecast the market in North America and Europe on the basis of mode of treatment, products, and regions
• To provide detailed information regarding major factors influencing the growth of the market in North America and Europe (drivers, restraints, opportunities, and industry-specific challenges)
• To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To strategically profile the key players and comprehensively analyze their market shares

As of 2015, Medtronic plc (Ireland), AngioDynamics, Inc. (U.S.), and biolitec AG (Austria) are some of the key players of the varicose vein treatment market in North America and Europe. Major market players were witnessed to adopt organic as well as (new product launches) as well as inorganic growth strategies (acquisitions and agreements) to enhance their market shares and positions during 2013-2016; with new product launch being the most-prominent growth strategy adopted by majority of market players. Several market players also pursued the strategy of strategic acquisitions to strengthen their market positions and enhance their R&D capabilities.

This research study involved the extensive use of secondary sources, directories, and databases (such as Hoovers, Bloomberg Business, Factiva, and Avention) to identify and collect information useful for this technology-based, market-oriented, and commercial study of the North America and Europe varicose vein treatment market. In-depth interviews were conducted with various primary respondents that mainly included key industry participants, subject-matter experts (SMEs), C & D level executives of key market players, and independent industry consultants, among others; to obtain and verify critical qualitative and quantitative information as well as to assess future market prospects of the varicose vein treatment industry.

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth emerging opportunities/threats which will impact 70% to 80% of worldwide companies' revenues.